ENTRY       K06255                      KO
NAME        HSPG2
DEFINITION  heparan sulfate proteoglycan 2 (perlecan)
PATHWAY     ko04512  ECM-receptor interaction
            ko05161  Hepatitis B
            ko05205  Proteoglycans in cancer
DISEASE     H00493  Heparan sulfate proteoglycan gene defects
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Environmental Information Processing
              Signaling molecules and interaction
               04512 ECM-receptor interaction
                K06255  HSPG2; heparan sulfate proteoglycan 2 (perlecan)
             Human Diseases
              Cancers
               05205 Proteoglycans in cancer
                K06255  HSPG2; heparan sulfate proteoglycan 2 (perlecan)
              Infectious diseases
               05161 Hepatitis B
                K06255  HSPG2; heparan sulfate proteoglycan 2 (perlecan)
            Exosome [BR:ko04147]
             Exosomal proteins
              Exosomal proteins of other body fluids (saliva and urine)
               K06255  HSPG2; heparan sulfate proteoglycan 2 (perlecan)
            Cell adhesion molecules and their ligands [BR:ko04516]
             2. Integrin Family
              Beta1 integrins
               VLA-2
                ITGB1; integrin beta 1
                 K06255 HSPG2; heparan sulfate proteoglycan 2 (perlecan)
             7. Others
              DAG1; dystroglycan 1
               K06255 HSPG2; heparan sulfate proteoglycan 2 (perlecan)
            Proteoglycans [BR:ko00535]
             Extracellular matrix (ECM) proteoglycans
              Basement membrane proteoglycans
               K06255  HSPG2; heparan sulfate proteoglycan 2 (perlecan)
GENES       HSA: 3339(HSPG2)
            PTR: 100613114(HSPG2)
            PPS: 100969025(HSPG2)
            GGO: 101138254(HSPG2)
            PON: 100446648(HSPG2)
            MCC: 707213(HSPG2)
            MCF: 102145976(HSPG2)
            MMU: 15530(Hspg2)
            CGE: 100689041(Hspg2)
            HGL: 101700294(Hspg2)
            TUP: 102493755(HSPG2)
            CFA: 403440(HSPG2)
            AML: 100467831(HSPG2)
            FCA: 101094520(HSPG2)
            PTG: 102954270(HSPG2)
            BTA: 444872(HSPG2)
            BOM: 102271087(HSPG2)
            PHD: 102317431(HSPG2) 102323898
            CHX: 102188640(HSPG2)
            SSC: 100517288(HSPG2)
            CFR: 102522322(HSPG2)
            BACU: 103016583(HSPG2)
            LVE: 103071665(HSPG2)
            ECB: 100071701(HSPG2)
            MYB: 102241192(HSPG2) 102255357
            MYD: 102756550(HSPG2)
            PALE: 102887886(HSPG2)
            MDO: 100617792(HSPG2)
            SHR: 100926296(HSPG2)
            OAA: 100088985(HSPG2) 100093007
            GGA: 429806(HSPG2)
            FAB: 101809010(HSPG2)
            PHI: 102108967(HSPG2)
            FPG: 101918976
            FCH: 102055079
            CLV: 102095921
            ASN: 102377486(HSPG2)
            AMJ: 102559592(HSPG2)
            CMY: 102942490(HSPG2)
            PBI: 103053870(HSPG2)
            XTR: 100494785(hspg2)
            DRE: 565429(hspg2)
            TRU: 101064605 101065556 101065784 101066010
            MZE: 101473055
            OLA: 101159991
            XMA: 102217130 102224055
            LCM: 102366028(HSPG2)
            CMK: 103181437(hspg2)
            BFO: BRAFLDRAFT_282197
            CIN: 100186716
            SPU: 754561
            NVE: NEMVE_v1g21768
            TAD: TRIADDRAFT_26220
REFERENCE   PMID:18826258
  AUTHORS   Whitelock JM, Melrose J, Iozzo RV
  TITLE     Diverse cell signaling events modulated by perlecan.
  JOURNAL   Biochemistry 47:11174-83 (2008)
///
